Purpose: To promote understanding of cognitive impairment in multiple sclerosis (MS),
recommend optimal screening, monitoring, and treatment strategies, and address barriers to …

Cognitive impairment is a common and devastating manifestation of multiple sclerosis (MS).
Although disease-modifying therapies have been efficacious for reducing relapse rates in …

Digital therapeutics (DTx) is a section of digital health defined by the DTx Alliance as
“delivering evidence-based therapeutic interventions to patients that are driven by software …

Higher order speeded cognitive abilities depend on efficient coordination of activity across
the brain, rendering them vulnerable to age reductions in structural and functional brain …

Objective To update the clinical recommendations for cognitive rehabilitation of people with
multiple sclerosis (MS), based on a systematic review of the literature from 2007 through …

Multiple sclerosis (MS) is a neurological disorder affecting the central nervous system and
features extensive functional brain changes that are poorly understood but relate strongly to …

Multiple sclerosis is a debilitating disorder resulting from scattered lesions in the central
nervous system. Because of the high variability of the lesion patterns between patients, it is …

Rehabilitation is recognized to be important in ameliorating motor and cognitive functions,
reducing disease burden, and improving quality of life in patients with multiple sclerosis …

Cognitive training (CT) is an increasingly popular, non-pharmacological intervention for
improving cognitive functioning in neurodegenerative diseases and healthy aging. Although …

Cognitive deficits are common in multiple sclerosis (MS), documented at many stages of the
disease. Both structural and functional neuroimaging have demonstrated a relationship with …